Investors

Investor Overview

Organovo is a pioneer in the development of human primary cell 3-D bioprinted tissues. The primary effort to develop a human therapeutic liver tissue candidate was halted and the company restructured to focus on utilizing its tissues for disease modeling and drug discovery, with the therapeutic liver tissue development on hold pending additional advances. 

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

ONVO 3mo Stock Chart
ONVO 6mo Stock Chart
ONVO 1yr Stock Chart
Duration
© 2022 Organovo Holdings, Inc. 6275 Nancy Ridge Drive, Suite 110 San Diego, CA 92121